Innate Pharma(IPHA) - 2024 Q2 - Quarterly Report

INNATE PHARMA SA HALF-YEAR FINANCIAL REPORT JUNE 30, 2024 INNATE PHARMA S.A. French société anonyme governed by an Executive Board and a Supervisory Board with a share capital of 4,049,171.60 euros composed of 80,969,357 ordinary shares, and 14,075 preferred shares with a nominal value of 0.05 euros each Registered office: 117, Avenue de Luminy, F-13009 Marseille, France Registered with the Company and Trade Register of Marseille under number 424 365 336 The following interim condensed consolidated financia ...